Cornelia Wiegand

10PUBLICATIONS
10CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Predictive and prognostic markersHealth and ecological risk assessmentAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 14, 2023
Treatment with a red-laser-based wound therapy device exerts positive effects in models of delayed keratinocyte and fibroblast wound healing.

Cornelia Wiegand, Annegret Dirksen, Jörg Tittelbach

|Feb 25, 2022
Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model.

Sarah Fink, Anke Burmester, Uta-Christina Hipler

|Feb 08, 2022
Effect of a DACC-coated dressing on keratinocytes and fibroblasts in wound healing using an in vitro scratch model.

Bianka Morgner, Johanna Husmark, Anna Arvidsson

|Nov 12, 2021
Point mutations in the squalene epoxidase erg1 and sterol 14-α demethylase erg11 gene of T indotineae isolates indicate that the resistant mutant strains evolved independently.

Anke Burmester, Uta-Christina Hipler, Peter Elsner

|Apr 19, 2021
Redox Enzymes of the Thioredoxin Family as Potential and Novel Markers in Pemphigus.

P Sliwiak, E Folwarczny, D Didona

|Jul 30, 2020
Indian Trichophyton mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance.

Anke Burmester, Uta-Christina Hipler, Silke Uhrlaß

Pageof 2

Frequent Collaborators

2 joint publications

Anke Burmester

1 joint publications

E Folwarczny

1 joint publications

D Didona

1 joint publications

E M Hanschmann